معرفی
Dr Alexander Greenhough is the Wallscourt Associate Professor at the School of Applied Sciences, University of the West of England (UWE Bristol), leading their long-term health conditions research programme. He holds an honorary Senior Lecturer position at the University of Bristol's School of Cellular and Molecular Medicine. His research focuses on cancer cell biology, tumor microenvironment dynamics, and translational cancer research. Dr Greenhough completed his BSc at the University of Warwick and PhD at the University of Bristol under Prof Chris Paraskeva. He has secured significant funding from Bowel Cancer UK, Sosei Heptares, BBSRC, and the Wellcome Trust.
- Education: BSc (Warwick), PhD (Bristol), PGCertHE, FHEA
- Roles: Research-led teaching, module leadership (Cell Signalling and Disease, MSc Health Technology), and supervising doctoral students
- Key Collaborations: CRUK Beatson Institute, University of Sussex, University Hospitals Bristol, University of Bath
His research integrates 3D organoid models, omics technologies, and live-cell imaging to study hypoxia-driven signaling in cancer. Goals include identifying druggable targets for cancer treatment and translating findings into clinical applications. Notable publications include work in EMBO Molecular Medicine and Cancer Epidemiology, Biomarkers and Prevention.
Awards & Grants:
- Wellcome Trust Seed Award (2019-2023)
- Bowel Cancer UK Pilot Grant (2019-2023)
- Multiple BBSRC/Sosei Heptares-funded PhD studentships
Teaching & Outreach: Leads the MSc Health Technology programme and engages in public talks, including a BBC Radio Bristol interview (2018). His teaching emphasizes research integration across biomedical, biological, and healthcare sciences.
Labs/Teams: Based at UWE's Centre for Biomedical Research, collaborating with Bristol University and industry partners like Sosei Heptares.
